Correspondence 0001104659-23-069236 from Fisher Wallace Laboratories, Inc. (CIK 0001787792)
Fisher Wallace Laboratories, Inc. (CIK 0001787792)
Date: June 8, 2023 · CIK: 0001787792 · Accession: 0001104659-23-069236
AI Filing Summary & Sentiment
Letter
Via Edgar Securities and Exchange Commission Washington, D.C. 20549-7410 Attn: Abby Acams Re: Fisher Wallace Laboratories, Inc. Post-Qualification Amendment
Dear Ms. Adams:
On behalf of our client, Fisher Wallace Laboratories, Inc., we hereby request qualification of the above-referenced offering statement at 2 p.m., Eastern Time, on June 8, 2023, or as soon thereafter as is practicable.
If you should require any additional information or clarification, please do not hesitate to contact me at 949-887-8877.
Very truly yours,
/Jeffrey S. Marks/
Show Raw Text
CORRESP
1
filename1.htm
Jeffrey S. Marks, Esq.
9 Chatelaine
Newport Coast, California 92657
(949) 887-8877
June 6, 2023
Via Edgar
Securities and Exchange Commission
100 F. Street, NE
Washington, D.C. 20549-7410
Attn: Abby Acams
Re:
Fisher Wallace Laboratories, Inc.
Post-Qualification Amendment
Dear Ms. Adams:
On behalf of our client, Fisher Wallace Laboratories,
Inc., we hereby request qualification of the above-referenced offering statement at 2 p.m., Eastern Time, on June 8, 2023, or as soon
thereafter as is practicable.
If you should require any additional information
or clarification, please do not hesitate to contact me at 949-887-8877.
Very truly yours,
/Jeffrey S. Marks/
Jeffrey S. Marks